There is no evidence that vaccines could cause harm to people who have recovered from COVID-19

 Newswise
7-May-2021 1:40 PM EDT, by Newswise

Fact Check By: Craig Jones, Newswise

Truthfulness: False

Claim:

Some experts say the science to support vaccinating those primed with COVID doesn’t exist and there’s a potential risk of harm, including death, in vaccinating those who’ve already had the disease or were recently infected.

Claim Publisher and Date: The Defender on 1921-04-05

An article published by Robert F. Kennedy Jr.’s anti-vaccination organization and widely shared on social media questions the need of vaccinating those who’ve already recovered from COVID-19. The article says there’s a "potential risk of harm, including death" in getting the vaccines. We report this claim as false. There is no evidence that vaccinating people who had previously had COVID is resulting in an increased risk of adverse events. In fact, there is some evidence that getting vaccinated after infection increases your immunity exponentially. See below.

The University of Miami Health System is currently conducting a National Institute of Allergey and Infectious Diseases-sponsored (NIH) clinical trial to evaluate how long immunity lasts after a person has had COVID-19, receives the vaccine, or both. The study is looking at immunity conferred by B cells, but also longer-term immunity that is conferred by T cells. This trial will help determine how long antibodies are present in the body for both populations and can protect the individual from infection.

According to this preliminary and ongoing research evaluating the antibody titers of vaccinated individuals who have received a single mRNA vaccine has shown that titers of vaccinees with preexisting immunity (i.e.: previous COVID-19 infection) were 10 to 45 times higher than vaccinees without preexisting immunity (i.e.: no previous COVID-19 infection) at the same time points after the first vaccine dose (e.g., 25 times as high at 13 to 16 days). Their titers also exceeded the median antibody titers measured in participants without preexisting immunity after the second vaccine dose by more than a factor of 6. No substantial difference was noted in the dynamics of antibody responses elicited by the Pfizer and Moderna vaccines after the first dose.

The trial is ongoing and further research is being conducted but initial data seems to be showing that individuals who previously had COVID-19 and then were vaccinated have a higher level of antibody protection.

The "Frequently Asked Questions about COVID-19 Vaccination" section of the Centers for Disease Control and Prevention site states that people who’ve already had COVID-19 should get vaccinated. See below.

Yes, you should be vaccinated regardless of whether you already had COVID-19. That’s because experts do not yet know how long you are protected from getting sick again after recovering from COVID-19. Even if you have already recovered from COVID-19, it is possible—although rare—that you could be infected with the virus that causes COVID-19 again. 



Filters close

Showing results

110 of 5861
Released: 23-Jun-2021 12:10 PM EDT
Phone swabs can accurately detect COVID-19
University College London

An accurate, non-invasive, and low-cost method of testing for COVID-19 using samples taken from the screens of mobile phones has been developed by a team led by UCL researchers at Diagnosis Biotech.

Newswise: NIH study suggests COVID-19 prevalence far exceeded early pandemic cases
Released: 23-Jun-2021 11:35 AM EDT
NIH study suggests COVID-19 prevalence far exceeded early pandemic cases
National Institute of Biomedical Imaging and Bioengineering

In a new study, NIH researchers report that the prevalence of COVID-19 in the United States during spring and summer of 2020 far exceeded the known number of cases and that infection affected the country unevenly.

Released: 23-Jun-2021 11:25 AM EDT
Half of young adults with covid-19 have persistent symptoms 6 months after
University of Bergen

A paper published in the prestigious journal Nature Medicine on long-COVID, describes persistent symptoms six months after acute COVID-19, even in young home isolated people.

Newswise:Video Embedded covid-19-vaccine-hesitancy-dr-vin-gupta-narrates-new-american-thoracic-society-video
VIDEO
Released: 23-Jun-2021 9:40 AM EDT
COVID-19 Vaccine Hesitancy: Dr. Vin Gupta Narrates New American Thoracic Society Video
American Thoracic Society (ATS)

The American Thoracic Society rolls out a new video to address vaccine hesitancy and answer common questions amid the COVID-19 pandemic.

18-Jun-2021 11:00 AM EDT
Had COVID-19? One Vaccine Dose Enough; Boosters For All, Study Says
American Chemical Society (ACS)

A new study in ACS Nano supports increasing evidence that people who had COVID-19 need only one vaccine dose, and that boosters could be necessary for everyone in the future.

Released: 22-Jun-2021 5:10 PM EDT
Tecnología de inteligencia artificial y ECG puede rápidamente descartar infección por COVID-19
Mayo Clinic

La inteligencia artificial puede ofrecer un manera de determinar con exactitud que una persona no está infectada con la COVID-19. Un estudio internacional y retrospectivo descubrió que la infección por SARS-CoV-2, el virus que causa la COVID-19, provoca sutiles cambios eléctricos en el corazón. Un electrocardiograma (ECG) mediado por inteligencia artificial detecta estos cambios y puede servir como una prueba rápida y confiable para descartar la infección por COVID-19.

Released: 22-Jun-2021 4:45 PM EDT
Penn Medicine to Use $1M from City of Philadelphia for Additional Community Vaccination Clinics
Perelman School of Medicine at the University of Pennsylvania

Penn Medicine will continue its collaboration with the West and Southwest Philadelphia communities to operate a series of COVID-19 vaccine clinics in partnership with community organizations, faith-based institutions, restaurants, barbershops, and even professional sports teams thanks to $1 million in funding from the City of Philadelphia, in partnership with PMHCC.

Released: 22-Jun-2021 12:30 PM EDT
Political Variables Carried More Weight Than Healthcare in Government Response to COVID-19
Binghamton University, State University of New York

Political institutions such as the timing of elections and presidentialism had a larger influence on COVID-19 strategies than the institutions organizing national healthcare, according to a research team led by a professor at Binghamton University, State University of New York.

22-Jun-2021 12:00 PM EDT
Study Testing How Well COVID-19 Vaccine Prevents Infection and Spread of SARS-CoV-2 Among University Students Now Expands to Include Young Adults Beyond the University Setting
Covid-19 Prevention Network (CoVPN)

The Prevent COVID U study, which launched in late March 2021 to evaluate SARS-CoV-2 infection and transmission among university students vaccinated with the Moderna COVID-19 Vaccine, has expanded beyond the university setting to enroll young adults ages 18 through 29 years and will now also include people in this age group who choose not to receive a vaccine.

Newswise: First Wave COVID-19 Data Underestimated Pandemic Infections
18-Jun-2021 8:30 AM EDT
First Wave COVID-19 Data Underestimated Pandemic Infections
American Institute of Physics (AIP)

Two COVID-19 pandemic curves emerged within many cities during the one-year period from March 2020 to March 2021. Oddly, the number of total daily infections reported during the first wave is much lower than that of the second, but the total number of daily deaths reported during the first wave is much higher than the second wave.


Showing results

110 of 5861

close
1.27405